A Controlled Trial of Phenylbutazone, Oxyphenbutazone, and a Placebo in the Treatment of Rheumatoid Arthritis

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.20.2.161
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Aggressive Treatment in Early Rheumatoid Arthritis: A Randomised Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

A Controlled Trial of Nandrolone Decanoate in the Treatment of Rheumatoid Arthritis in Postmenopausal Women.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1987English

Limited Effect of Sulphasalazine Treatment in Reactive Arthritis. A Randomised Double Blind Placebo Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1997English

Chloroquine and Rheumatoid Arthritis: A Short-Term Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1956English

Controlled Trial of Methotrexate Versus 10-Deazaaminopterin in the Treatment of Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

OP0151 Docosahexaenoic Acid Treatment of Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study

2017English

Long-Term Use of Phenylbutazone in Rheumatoid Arthritis

BMJ
1960English

A Randomised, Double-Blind, Placebo-Controlled Trial of a Recombinant Version of Human -Fetoprotein (MM-093) in Patients With Active Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy